Drawing for UTHEALTH

USPTO serial 77975596

UTHEALTH

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BELZER, LYDIA M
Law office
TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with UTHEALTH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer L. Whitelaw

JENNIFER L. WHITELAW WHITELAW LEGAL GROUP3838 TAMIAMI TRL N 3TH FLNAPLES, FL 34103-3590UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Botanical extracts for use in the manufacture of nutraceuticals; chemical extracts and active principles extracted from medicinal plants for use in the manufacture of nutraceuticals; botanical extracts for use in the manufacture of pharmaceutical preparations in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, tincture, suppositories; and botanicals, and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends other than essential oils, all for use in the manufacture of nutritional supplements and vitaminsACTIVE—
005Nutritional supplements; herbal products, namely, medicated skin balms; herbal products for medicinal purposes, namely, herbal extracts for use as nutritional and dietary supplements; herbal products for medicinal purposes, namely, medicinal herbal extracts and medicated syrups containing herbal extracts; medicinal herb extracts; medicinal herb extracts for medicinal purposes; plant extracts for medical purposes and nutritional purposes, namely, as nutritional supplements; botanical extracts in the nature of plant extracts used in pharmaceutical preparations for the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory or cancer conditions and available in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, tincture, and suppositories; medicinal extracts in the nature of plant extracts used in pharmaceutical preparations for the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory or cancer conditions and available in the form of lotions, creams, and topical analgesics and anesthetics, tablets, capsules, pills, lozenges, tincture, and suppositories; herbal products, namely, herbal powders being nutritional supplements; herbal products, namely, herbal meal replacement powders for dietary and nutritional purposes; herbal products, namely, aromatherapy packs containing herbs used for relief from headaches, insomnia and sinus discomfort; nutritional dietary supplements; oral preparations being vitamins containing herbs or herbal extracts used to maintain health and for a wide variety of physical conditions, namely, for the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory or cancer conditions; herbal products for medical use, namely, medicated ointments, medicated oils, medicinal drinks, and bacterial poisons for medical purposes, all for use in the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory or cancer conditions; botanical extracts sold as an integral ingredient in nutraceuticals for the treatment of, or relief of symptoms in, infectious diseases and adverse human health conditions, namely, infection, degenerative, muscular, pulmonary, skeletal, endocrine, immune, neurological, cardiovascular, metabolic, inflammatory or cancer conditions; yeast extracts for medical and nutritional supplement purposes; vitamin and mineral preparations intended for use as dietary supplements; vitamins; food supplements; botanical extracts sold as an integral ingredient in nutritional supplements; nutraceuticals, namely, vitamins and food supplements; food for medically restricted diets; food supplements, namely, anti-oxidants; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; oral analgesics; topical analgesics; botanical extracts sold as component ingredient in nutraceuticals; botanicals and botanical blends, herbals and herbal blends, botanical extracts and botanical extract blends, flavor extracts and flavor extract blends other than essential oils and not being food flavorings, all sold as integral components and ingredients of nutritional supplements and vitaminsACTIVE—
030Herbal infusionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Jan 26, 2010MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 26, 2010ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 17, 2009GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Jun 17, 2009GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 17, 2009CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 21, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 21, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 1, 2009ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 20, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 20, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 27, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 27, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 27, 2008ALIEASSIGNED TO LIE—
Oct 10, 2008MAILPAPER RECEIVED—
Jun 6, 2008ATRVATTORNEY REVIEW COMPLETED—
May 19, 2008DPCCDIVISIONAL PROCESSING COMPLETE—
May 14, 2008ACECAMENDMENT FROM APPLICANT ENTERED—
May 14, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2008ALIEASSIGNED TO LIE—
May 12, 2008DRRRDIVISIONAL REQUEST RECEIVED—
May 12, 2008MAILPAPER RECEIVED—
Apr 4, 2008GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2008GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 4, 2008CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2008DOCKASSIGNED TO EXAMINER—
Feb 28, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance